TLDR Facial hidradenitis suppurativa can be mistaken for acne but requires different treatment.
The article discusses the potential for facial hidradenitis suppurativa (HS) to be mistaken for acne vulgaris (AV). Studies have shown a higher prevalence of AV in patients with HS, with one large study identifying a 15.2% prevalence among 48,085 adult HS patients. Differentiating between HS and AV is challenging due to overlapping clinical features, but certain characteristics like excess sebum and closed comedones are distinctive of AV, while rope-like scars suggest HS. Facial HS is more common in men and may be underdiagnosed, potentially leading to an overestimation of AV prevalence. Proper diagnosis is crucial as treatments differ, with HS potentially benefiting from combined antibiotics and tumor necrosis factor inhibitors.
27 citations,
December 2015 in “Mayo Clinic Proceedings” The document concludes that lifestyle changes and medical treatments can significantly reduce symptoms of Hidradenitis Suppurativa, a chronic skin condition.
12 citations,
January 2012 in “Dermatology” Finasteride helped treat a 28-year-old's facial skin condition.
January 2017 in “Springer eBooks” The document explains various skin conditions and their treatments.
January 2018 in “Springer eBooks” Hidradenitis Suppurativa is likely an autoinflammatory disease, and better understanding its causes could improve treatments.
3 citations,
May 2018 in “Experimental Dermatology” Young HS patients often have other physical and mental health issues, and research on HS covers a wide range of topics including genetics, triggers, treatments, and the need for more data.
41 citations,
June 2016 in “Reviews in endocrine and metabolic disorders” Hidradenitis suppurativa may be related to hormones and patients often have metabolic disorders; more research is needed to understand this connection.
38 citations,
September 2014 in “Cell and Tissue Research” The hair follicle infundibulum plays a key role in skin health and disease, and understanding it better could lead to new skin disease treatments.
